pregnant patient – Communicable Diseases Research

Examining the impact of trimester of diagnosis on COVID-19 disease progression in pregnancy

Research article

Published on 2022-11-012022-10-05
Journal: American journal of obstetrics & gynecology MFM
[Category] 치료기술,

Characteristics and treatment of hospitalized pregnant women with Coronavirus Disease 2019, COVID-19

Research article

Published on 2022-11-012022-10-05
Journal: American journal of obstetrics & gynecology MFM
[Category] 임상, 치료법,

[키워드] 95% confidence interval Admission age black calculated Clinical characteristics clinical trials Cohort COVID-19 COVID-19 vaccination discharge estimate Hispanic Hospitalized identify implementation Inclusion increased risk laboratory-confirmed SARS-CoV-2 infection Latino less MOST network nonpregnant outcome Patient Pregnancy pregnant pregnant patient pregnant women Prevalence prevalence ratio Probability propensity score matching receive Remdesivir reproductive requiring supplemental oxygen SARS-CoV-2 steroids spontaneous abortion Stillbirth Surveillance symptomatic symptoms of COVID-19 Systemic steroid Treatment vaccination with COVID-19 women
[DOI] 10.1016/j.ajogmf.2022.100715 [Article Type] Research article

Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies

Article

Published on 2022-09-152022-11-15
Journal: Frontiers in Immunology
[Category] SARS, 진단,

[키워드] Admission anti-beta2glycoprotein I antibodies Anti-phospholipid antibodies anti-phospholipid syndrome antibodies antibody autoantibodies Causality checked Cohort collected Comorbidities Complication complications contributed COVID-19 de novo Department described diagnosed disorders elicited Frequency HELLP syndrome Hospitalized hypertensive ICU admission IgG IgM induce Infection information lack Lupus morbidity Nasopharyngeal swab Neonatal Obstetric occurred Occurrence pandemic pathogenic patients positive preeclampsia Pregnancy pregnancy morbidity. pregnant patient pregnant women Prospective Study raised remained required Research Risk factors SARS-CoV-2 SARS-COV-2 infection significantly single-center symptomatic SARS-CoV-2 infection the SARS-CoV-2 thrombosis titre women
[DOI] 10.3389/fimmu.2022.953043 PMC 바로가기

Evaluation of the tolerability of monoclonal antibody therapy for pregnant patients with COVID-19

Article

Published on 2022-09-012022-11-15
Journal: The journal of obstetrics and gynaecology research
[Category] COVID19(2023년), SARS, 변종, 진단,

Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemic

Article

Published on 2022-09-012022-10-05
Journal: American journal of obstetrics & gynecology MFM
[Category] COVID19(2023년), SARS, 임상, 진단,

[키워드] administration Admission adverse events anaphylaxis Atlanta authorization benefit casirivimab and imdevimab Clinical course Clinical outcome Cohort cohort of patient COVID-19 COVID-19 illness COVID-19 pandemic COVID-19 therapeutics death drug Effect Efficacy eligible Emergency food groups high-risk population higher risk Hospital stay Hospitalization Hypothesis increased risk individual Infection instance intensive care less Maternal morbidity Memorial monoclonal antibodies monoclonal antibody morbidity and mortality need for oxygen Neonatal Neonatal morbidity no significant difference nonpregnant novel therapies offered outcome outcomes Oxygen requirement patients with SARS-CoV-2 pharmacologic treatment Placebo polymerase chain positive Pregnancy pregnant pregnant patient pregnant patients pregnant population receive reduce reduced REGEN-COV released resolved Respiratory illness retrospective cohort study risk Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 viral load severe COVID-19 severe disease Shortness of breath shown side statistically significant difference Symptom tested therapy thought treated Treatment treatment guideline Trial trials ventilatory support were excluded worsening
[DOI] 10.1016/j.ajogmf.2022.100673 [Article Type] Article

Comparison of Severe Maternal Morbidities Associated With Delivery During Periods of Circulation of Specific SARS-CoV-2 Variants

특정 SARS-CoV-2 변이체의 순환 기간 동안 분만과 관련된 심각한 산모 이환율의 비교

Multicenter Study

Published on 2022-08-012022-09-11
Journal: JAMA Network Open
[Category] SARS, 변종,

[키워드] age Alpha Alpha variant amplification analyzed association B.1.1.7 B.1.617.2 cause center characterized clinical variable cohort study complications Control COVID-19 defined delivery Delta delta variant demographic and clinical variables disease control dominant evaluate event events Evidence evidence of example health system highest Hospitalization individual Infection IQR Maternal median morbidity multicenter nucleic acid nucleic acid amplification test Odds ratio omicron outcome outcomes over pandemic Patient patients with SARS-CoV-2 Period predominant pregnant patient pregnant patients prevention preventive measures Primary outcome reflected Respiratory complications retrospective cohort study risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid secondary Secondary outcomes severity of COVID-19 significantly higher Specific Strains test result the SARS-CoV-2 type strain Variation viral strain viral strains was increased while wild-type strain
[DOI] 10.1001/jamanetworkopen.2022.26436 PMC 바로가기 [Article Type] Multicenter Study

Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients

혈청 호중구 젤라티나제 관련 리포칼린 농도는 임산부의 COVID-19 중증도와 유의하게 관련되어 있습니다

Article

Published on 2022-06-012022-09-11
Journal: Saudi medical journal
[Category] MERS, 바이오마커,

Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia

심각한 COVID-19 유발 저산소증이 있는 4명의 임신한 환자에서 성공적인 정맥 면역글로불린(IVIG) 치료의 사례 시리즈

Case Reports

Published on 2022-05-142022-09-12
Journal: The American journal of case reports
[Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] active infection acute respiratory distress addition Administered age ARDS benefit breathing room air case sery clinical trials Comorbidity complications COVID COVID-19 vaccine discharged home excluded gestational age glucocorticoid greater hospital discharge Hospitalization Hospitalized hospitalized patient Immunoglobulin Influenza initial mean hospital stay moderate-to-severe COVID-19 morbidity other diseases other respiratory virus Patient Pregnancy pregnant patient pregnant women risk Safe SARS-CoV-2 Sery severe COVID-19 severe COVID-19 disease severe respiratory symptom symptom onset syndrome therapeutic therapy Treatment Two patient vaginal delivery with COVID-19
[DOI] 10.12659/AJCR.936734 PMC 바로가기 [Article Type] Case Reports

Differences in the neutrophil/lymphocyte ratio and the platelet/lymphocyte ratio in pregnant women with and without COVID-19

Observational Study

Published on 2022-05-012022-10-05
Journal: International journal of gynaecology and obstetric
[Category] 임상,

SARS-2 COVID-19-induced immunity response, a new prognostic marker for the pregnant population correlates inversely with neonatal Apgar score

Original Paper

Published on 2022-03-052022-10-29
Journal: Infection
[Category] COVID-19, COVID19(2023년), MERS, SARS,

[키워드] accompanied Admission APGAR score appear association Biomarkers clinician collected Complication complications correlated COVID-19 COVID-19 infection COVID-19 patient defined distress exhibited facilitate haematological parameter Haematology help Hypothesis hypothesised immune response Immunity impacted Intensive Intervention Laboratory monocyte mother Neonatal Neonate neutrophil non-pregnant females outcome outcomes Patient perinatal health populations predict Pregnancy pregnant pregnant female pregnant females pregnant patient pregnant patients pregnant population prevalent Prognosis Prognostic marker PROTECT reduce response Result significantly significantly lower subject tested WBC
[DOI] 10.1007/s15010-022-01773-3 PMC 바로가기 [Article Type] Original Paper